Andrea HAWE

City:

München

Country:

Germany

Published Applications:

Last publication date:

2024-09-05

Top Assignees for applications by Andrea HAWE

The entities that hold a legal rights for patent applications filed by inventor HAWE Andrea:

Rose Pharma LLC 2 Hamilton, Bermuda
AIC246 AG & Co. KG 2 Wuppertal, Germany
Rose Pharma Inc. 2 Virginia Beach, VA United States
Novo Nordisk A/S 1 Bagsvaerd, Denmark

Recent patent applications by HAWE Andrea

Andrea HAWE from München, DE has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2024-09-05

US20240293515A1

Human necessities

STABLE LIQUID FORMULATIONS OF GLUCAGON-LIKE PEPTIDE 1 OR ANALOGUES THEREOF

#2 | 2023-05-04

US20230138444A1

Human necessities

Pharmaceutical compositions comprising 2-[(4S)-8-fluoro-2-[4-(3-methoxyphenyl)piperazin-1-yl]-3-[2-methoxy-5-(trifluoromethyl)phenyl]-4H-quinazolin-4-yl]acetate and sodium ions

#3 | 2023-03-30

US20230095980A1

Human necessities

Sodium 2-[(4S)-8-fluoro-2-[4-(3-methoxyphenyl)piperazin-1-yl]-3-[2-methoxy-5-(trifluoromethyl)phenyl]-4H-quinazolin-4-yl]acetate and pharmaceutical compositions thereof

#4 | 2021-09-16

US20210283226A1

Human necessities

Methods of treatment with stable liquid formulations of glucagon-like peptide 1 or analogues thereof

#5 | 2021-06-10

US20210169987A1

Human necessities

Stable liquid formulations of glucagon-like peptide 1 or analogues thereof

#6 | 2020-11-19

US20200362023A1

Chemistry; metallurgy

Lyophilized formulation of a monoclonal antibody against transthyretin

InventorID:

2909490 ⎘